glucagon like peptide 1 glp 1 receptor agonist Glucagon-like 1(GLP-1) agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Non-insulin injectable antidiabetic drugs -

Blood-brain barrier Permeable nanoparticles for Alzheimers disease treatment by selective mitophagy of microglia

We discuss: How much exercise is truly healthy, and when it starts working against you Simple training shifts that build strength and stamina while protecting long-term health What recovery tools can actually speed healing and reduce inflammation Can light and oxygen really reset your bodys rhythms and improve sleep

M.SabriM

The peptide was first identified in 1973 by Loren Pickart during research on human plasma, where he observed that a small copper-peptide complex was present in younger blood samples at higher concentrations than in older ones

Aging 2 , 3037 (2018)